Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Martine Rothblatt

Martine Rothblatt

Chair and Chief Executive, United Therapeutics

Appears in 1 story

Notable Quotes

Rothblatt has said the approval moves the company toward technologies that create "an unlimited supply of transplantable organs."

Stories

FDA approves United Therapeutics LungFX to reassess discarded donor lungs

New Capabilities

Leading the company's push toward a manufactured organ supply

More than 8 in 10 donor lungs recovered from deceased donors never reach a patient. On June 29, 2026, the FDA approved a device built to change that math. United Therapeutics won premarket approval for LungFX, a system that keeps donor lungs warm, ventilated, and pumped with fluid outside the body so transplant teams can re-examine organs they had already rejected.

Updated 2 hours ago